Shortened Questionnaire on Quality of Life for Inflammatory Bowel Disease
Authors:
- F. CasellasFCF. Casellas
- G. FontanetGFG. Fontanet
- L. PrietoLPL. Prieto
- J-R MalageladaJMJ-R Malagelada
- 1 July 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 10 (4) , 383-391
Abstract
Questionnaires for measuring quality of life in patients with inflammatory bowel disease usually include a large number of items and are time-consuming for both administration and interpretation. Our aim was to elaborate and validate a short quality-of-life questionnaire with the most representative items from the Spanish version of the 36-item Inflammatory Bowel Disease Questionnaire (IBDQ-36) using the Rasch analysis. The responses to 311 IBDQ-36 questionnaires from 167 patients with ulcerative colitis (UC) and 144 with Crohn's disease (CD) were analyzed. IBDQ-36 was shortened with successive Rasch analyses until all the remaining items showed acceptable separation and goodness-of-fit properties. Validation of the short questionnaire was studied in a new group of 125 patients by determining its validity and reliability. A 9-item short questionnaire was obtained (IBDQ-9). Its correlation with IBDQ-36 was excellent (r = 0.91). Correlation between IBDQ-9 and clinical indices of activity was statistically significant in UC (r = 0.70) and CD (r= 0.70). IBDQ-9 score discriminates adequately between patients in clinical remission or relapse (P < 0.01). Sensitivity to change was determined in 14 patients who improved clinically, showing significant IBDQ-9 changes between both determinations (P < 0.01), with an effect size of -2.67 in UC and -5.29 in CD. IBDQ-9 was also homogeneous, with a Cronbach's alpha of 0.95 in UC and 0.91 in CD. In 35-clinically stable patients, test-retest reliability was good, with a statistically-significant correlation between both questionnaires (r = 0.76 in UC and 0.86 in CD, P < 0.01) and an intraclass correlation coefficient of 0.82 in UC and 0.84 in CD. In conclusion, a short and valid questionnaire to measure quality of life in patients with inflammatory bowel disease was obtained using a new measurement model. Its use should facilitate comprehension of the impact of inflammatory bowel disease.Keywords
This publication has 30 references indexed in Scilit:
- Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease QuestionnaireAlimentary Pharmacology & Therapeutics, 2003
- Quality of Life of Greek Patients with Inflammatory Bowel DiseaseDigestion, 2001
- Validation of the Inflammatory Bowel Disease Questionnaire in Swedish Patients with Ulcerative ColitisScandinavian Journal of Gastroenterology, 2001
- The UK IBDQ—A British version of the inflammatory bowel disease questionnaireJournal of Clinical Epidemiology, 2000
- Validation of the Spanish Version of the Inflammatory Bowel Disease Questionnaire on Ulcerative Colitis and Crohn’s DiseaseDigestion, 1999
- Quality of Life in Inflammatory Bowel Disease: Background and DefinitionsJournal of Pediatric Gastroenterology and Nutrition, 1999
- Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's diseaseInternational Journal of Colorectal Disease, 1999
- Quality of Life in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1992
- A New Measure of Health Status for Clinical Trials in Inflammatory Bowel DiseaseGastroenterology, 1989
- Quality of Life in Patients with Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1988